PIMA530960
Kallikrein 13 Monoclonal Antibody (10H10A2C4), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA530960-Each-of-1 | In Stock | ₹ 32,485.00 |
PIMA530960 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 32,485.00
GST (18%): ₹ 5,847.30
Total Price: ₹ 38,332.30
Antigen
Kallikrein 13
Classification
Monoclonal
Concentration
1 mg/mL
Formulation
PBS with no preservative
Gene Accession No.
Q9UKR3
Gene Symbols
KLK13
Immunogen
Recombinant Human KLK13 protein (Met1-Ile262)
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG2a
Applications
ELISA
Clone
10H10A2C4
Conjugate
Unconjugated
Gene
KLK13
Gene Alias
DKFZp586J1923; Egfbp-2; kallikrein 13; kallikrein related peptidase 13; kallikrein related-peptidase 13; kallikrein-13; kallikrein-like gene 4; kallikrein-like protein 4; kallikrein-related peptidase 13; KLK13; KLK-13; KLKL4; KLK-L4; mGk-13
Host Species
Mouse
Purification Method
Protein A
Regulatory Status
RUO
Gene ID (Entrez)
26085
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Related Products
Description
- This product is preservative free
- It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%)
- This antibody has specificity for Human KLK13/Kallikrein 13
- Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis
- The novel KLK gene, KLK-L4, is expressed in a variety of tissues including prostate, salivary gland, breast, and testis
- Its expression is regulated by steroid hormones in breast cancer cell lines may be involved in the pathogenesis and/or progression of breast cancer.